References/Publications for Western/Immunoblot of Alt a 6

Check all              

Select PubMed ID Description
J Allergy Clin Immunol. 2000 Nov;106(5):887-95.

IgE-binding epitopes of enolases, a class of highly conserved fungal allergens.

Simon-Nobbe B(1), Probst G, Kajava AV, Oberkofler H, Susani M, Crameri R,
Ferreira F, Ebner C, Breitenbach M.

12432231 J Biomed Sci. 2002 Nov-Dec;9(6 Pt 2):645-55.

Characterization of enolase allergen from Rhodotorula mucilaginosa.

Chang CY(1), Chou H, Tam M, Tang RB, Lai HY, Shen HD.

11979043 Int Arch Allergy Immunol. 2002 Mar;127(3):181-90.

cDNA cloning and immunological characterization of a newly identified enolase
allergen from Penicillium citrinum and Aspergillus fumigatus.

Lai HY(1), Tam MF, Tang RB, Chou H, Chang CY, Tsai JJ, Shen HD.

34829261 J Fungi (Basel). 2021 Nov 16;7(11). pii: 974. doi: 10.3390/jof7110974.

Changes in the Sensitization Pattern to Alternaria alternata Allergens in
Patients Treated with Alt a 1 Immunotherapy.

Rodríguez D(1), Tabar AI(2)(3), Castillo M(1), Martínez-Gomariz M(1), Dobski
IC(1), Palacios R(1).

4% of the patients recognized Alt a 1. The percentage of recognition for Alt
a 3, Alt a 4, and/or Alt a 6, Alt a 7, Alt a 8, Alt a 10 and/or Alt a 15 was
6%, 21.9%, 12.5%, 12.5%, and 12.5% respectively. Of the 64 patients, 45 (70.3%)
only recognized Alt a 1 among the allergens present in the A. alternata extract.
Immunotherapy with Alt a 1 desensitizes treated patients, reducing their symptoms
and medication consumption through the elimination of Alt a 1 sensitization,
which is no longer present in the immunoblotting of some patients. There may be
gender differences in the pattern of sensitization to A. alternata allergens,
among others.

DOI: 10.3390/jof7110974
PMCID: PMC8618185
PMID: 34829261